Views & Analysis

Views & Analysis
Gene editing: beyond the hype

Gene editing: beyond the hype

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities.

Views & Analysis
A new approach to COVID-19 treatment

A new approach to COVID-19 treatment

While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr.